Preliminary studies of the effects of vascular adhesion protein-1 inhibitors on experimental corneal neovascularization

Journal of Neural Transmission

Volumn 118, Issue 7, 2011, Pages 1065-1069

  Énzsöly, Anna ^a   Dunkel, Petra ^a   Récsán, Zsuzsa ^a   Gyorffy, Hajnalka ^a   Tóth, Jeanette ^a   Marics, Gábor ^a   Bori, Zoltán ^a   Tóh, Miklós ^a   Zelkó, Romána ^a   Di Paolo, Maria Luisa ^b   Mátyus, Péter ^a   Németh, János ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Alkali burn model; Corneal neovascularization; Semicarbazide sensitive amine oxidase (SSAO); Vascular adhesion protein 1 (VAP 1)

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BEVACIZUMAB; LJP 1207; PROTEIN INHIBITOR; SEMICARBAZIDE; SZV 1287; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1; VASCULAR ADHESION PROTEIN 1 INHIBITOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BLINDNESS; CONFERENCE PAPER; CORNEA NEOVASCULARIZATION; DRUG EFFECT; ENDOTHELIUM CELL; EYE DISEASE; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VISUAL ACUITY;

AMINE OXIDASE (COPPER-CONTAINING); ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; CELL ADHESION MOLECULES; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; MALE; RABBITS;

EID: 80051666955     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0595-8     Document Type: Conference Paper

References (26)

1. Almulki L, Noda K, Nakao S, Hisatomi T, Thomas KL, Hafezi-Moghadam A (2010) Localization of vascular adhesion protein-1 (VAP-1) in the human eye. Exp Eye Res 90:26-32
2. Augustin AJ, Scholl S, Kirchhof J (2009) Treatment of neovascular age-related macular degeneration: current therapies. Clin Ophthalmol 3:175-182
3. Brown MM, Brown GC, Stein JD, Roth Z, Campanella J, Beauchamp GR (2005) Age-related macular degeneration: economic burden and value-based medicine analysis. Can J Ophthalmol 40:277-287 (Pubitemid 40942254)
4. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
5. Chang J, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Curr Opin Ophthalmol 12:242-249 (Pubitemid 32751680)
6. Ellenberg D, Azar DT, Hallak JA, Tobaigy F, Han KY, Jain S, Zhou Z, Chang J (2010) Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res 29:208-248
7. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564-572 (Pubitemid 38456293)
8. Hafezi-Moghadam A (2009) Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (VAP-1) inhibitor. PCT Int Appl WO2009/061830
9. Lee P, Wang CC, Adamis AP (1998) Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43:245-269 (Pubitemid 28558273)
10. Marttila-Ichihara F, Auvinen K, Elima K, Jalkanen S, Salmi M (2009) Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1 + CD11b + myeloid cells into tumors. Cancer Res 69:7875-7883
11. Marttila-Ichihara F, Castermans K, Auvinen K, oude Egbrink MGA, Jalkanen S, Griffioen AW, Salmi M (2010) Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice. J Immunol 184:3164-3173
12. Mátyus P, Magyar K, Pihlavisto M, Gyires K, Haider N, Wang Y, Woda P, Dunkel P, Tóth-Sarudy É, Túrós G (2010) Compounds for inhibiting semicarbazide-sensitive amine oxidase (SSAO)/vascular adhesion protin-1 (VAP-1) and uses thereof for treatment and prevention of diseases. PCT Int Appl WO2010/029379
13. Noda K, She H, Nakazawa T, Hisatomi T, Nakao S, Almulki L, Zandi S, Miyahara S, Ito Y, Thomas KL, Garland RC, Miller JW, Gragoudas ES, Mashima Y, Hafezi-Moghadam A (2008a) Vascular adhesion protein-1 blockade suppresses choroidal neovascularization. FASEB J 22:2928-2935
14. Noda K, Miyahara S, Nakazawa T, Almulki L, Nakao S, Hisatomi T, She H, Thomas KL, Garland RC, Miller JW, Gragoudas ES, Kawai Y, Mashima Y, Hafezi-Moghadam A (2008b) Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis. FASEB J 22:1094-1103 (Pubitemid 351519964)
15. Novack GD (2008) Pharmacotherapy for the treatment of choroidal neovascularization due to age-related macular degeneration. Annu Rev Pharmacol Toxicol 48:61-78 (Pubitemid 351738149)
16. Nussenblatt RB, Ferris F 3rd (2007) Age-related macular degeneration and the immune response: implications for therapy. Am J Ophthalmol 144:618-626
17. Salmi M, Jalkanen S (2009) Method for inhibiting angiogenesis or for treatment of cancer. PCT Int Appl WO2009/056671
18. Salter-Cid LM, Wang E, O'Rourke AM, Miller A, Gao H, Huang L, Garcia A, Linnik MD (2005) Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase. J Pharmacol Exp Ther 315:553-562 (Pubitemid 41500719)
19. Schmidt-Erfurth UM, Pruente C (2007) Management of neovascular age-related macular degeneration. Prog Retin Eye Res 26:437-451 (Pubitemid 46756380)
20. Shams N, Ianchulev T (2006) Role of vascular endothelial growth factor in ocular angiogenesis. Ophthalmol Clin North Am 19:335-344 (Pubitemid 44279356)
21. Smith DJ, Vainio PJ (2007) Targeting vascular adhesion protein-1 to treat autoimmune and inflammatory diseases. Ann NY Acad Sci 1110:382-388 (Pubitemid 350043027)
22. Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S (1998) Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 188:17-27 (Pubitemid 28328602)
23. Weih LM, Van Newkirk MR, McCarty CA, Taylor HR (2000) Agespecific causes of bilateral visual impairment. Arch Ophthalmol 118:264-269 (Pubitemid 30086214)
24. Yraola F, Albericio F, Royo M (2007) Inhibition of VAP1: quickly gaining ground as an anti-inflammatory therapy. Chem Med Chem 2:173-174
25. Zhang Z, Ma JX, Gao G, Li C, Luo L, Zhang M, Yang W, Jiang A, Kuang W, Xu L, Chen J, Liu Z (2005) Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization. Invest Ophthalmol Vis Sci 46(11):4062-4071 (Pubitemid 44264605)
26. 1). Microvasc Res 34:133-136 (Pubitemid 17114049)